SMS Pharmaceuticals Limited (NSE: SMSPHARMA) reports 6% YoY revenue growth in Q1 FY27, driven by high-value APIs and structural improvements.
CORONA Remedies Limited (CORONA) reports Q1 FY27 revenue and PAT growth of 21.9% and 30.1% Y-o-Y, driven by brand building and operational excellence.
Senores Pharmaceuticals Limited (SENORES) reports a robust Q1 FY27 with revenue up 36% and EBITDA & PAT surging by 87% and 56% respectively.
Marksans Pharma Limited (MARKSANS) stock gains 6% intraday to ₹261.7, showing a bounce despite the 6M trendline status being in breakdown. Full details inside.
Rubicon Research Limited (NSE: RUBICON) acquires its first US manufacturing facility in East Brunswick, NJ for USD 2.9 million.
Marksans Pharma Limited (NSE: MARKSANS) drops 5% intraday to ₹245.45, breaking below support in the Healthcare sector's Drug Manufacturers - General segment.
Rubicon Research Limited (NSE: RUBICON) stock price moves up 5% intraday to ₹1516.1, showing a strong upward trend in the Healthcare sector.
Marksans Pharma Limited (MARKSANS) stock breaks out, gaining 5% intraday to ₹277.5, clearing its 6M resistance trendline..
Marksans Pharma Ltd (MARKSANS) acquires ABCnow GmbH for €892,384 to enhance its European market presence and distribution network.
Rubicon Research Limited (NSE: RUBICON) extends gains by 5% intraday, nearing resistance but not clearing it yet. .